Аллергические болезни: диагностика и лечение - Паттерсон Р.
ISBN 5-9231-0011-8
Скачать (прямая ссылка):
46. Gelfand J.A. et al. Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities 11 N. Engl. J. Med. - 1976. - Vol. 295. - P. 1444.
47. Sheffer A.L. et al. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema // J. Allergy Clin. Immunol. - 1981. - Vol. 68. - P. 181.
48. Cicardi M. et al. Long-term treatment of hereditary angioedema with attenuated androgens: a survey of a 13-year experience 11 Ibid. - 1991. - Vol. 87. - P. 768.
49. Gelfand J.A. et al. Acquired Cl esterase inhibitor deficiency and angioedema: a review 11 Medicine (Baltimore). - 1979. - Vol. 58. - P. 321.
50. Frigas E. Angioedema with acquired deficiency of the С1 -inhibitor: a constellation of syndromes // Mayo Clin. Proc. - 1989. - Vol. 64. - P. 1269.
51. Donaldson V.H. et al. An autoantibody to Cl-inhibitor recognizes the reactive center of the inhibitors // J. Lab. Clin. Med. - 1996. - Vol. 127. - P. 229.
52. Bork КWitzke G. Long-term prophylaxis with Cl-inhibitor (Cl INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired Cl-inhibitor deficiency // J. Allergy Clin. Immunol. - 1989. - Vol. 83. - P. 677.
53. Gadek J.E. et al. Replacement therapy in hereditary angioedema: successful treatment of acute episodes with partially purified Cl inhibitor // N. Engl. J. Med. - 1976. - Vol. 295. - P. 1444.
54. Patterson R. et al. Vibratory angioedema: a hereditary type of physical hypersensitivity 11 J. Allergy Clin. Immunol. - 1972. - Vol. 50. - P. 174.
55. Metzger W.J. et al. Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity 11 Ibid. - 1976. - Vol. 57. - P. 605.
56. Wener M.H. et al. Occupationally acquired vibratory angioedema with secondary carpal tunnel syndrome 11 Ann. Intern. Med. - 1983. - Vol. 98. - P. 44.
57. Ting S. et al. Non-familial, vibration-induced angioedema // J. Allergy Clin. Immunol. - 1983. -Vol. 71.-P. 546.
58. Ghosh Schabani et al. Urticaria in children 11 Pediatr. Dermatol. - 1993. - Vol. 10. - P. 107.
59. Volonakis M. et al. Etiologic factors in childhood chronic urticaria 11 Ann. Allergy. - 1992. -Vol. 69.-P. 61.
60. Vaida G.A. et al. Testing for hepatitis В in patients with chronic urticaria and angioedema 11 J. Allergy Clin. Immunol. - 1983. - Vol. 72. - P. 193.
61. Sampson H.A. The role of food allergy and mediation release in atopic dermatitis 11 Ibid. - 1988. -Vol. 81.-P. 635.
62. Telez-Diaz G. et al. Prevalence of avocado allergy among atopic patients // Allergy. - 1995. -Vol. 16.-P. 241. ,
63. Bush R.K., Hefle S.L. Lessons and myths regarding cross-reacting foods 11 Allergy Proc. - 1995. -Vol. 16. - P. 245.
64. Dompmartin A. et al. Two cases of urticaria following fruit ingestion, with cross-sensitivity to latex // Contact Dermatitis. - 1994. - Vol. 30. - P. 250.
65. Vonkrog H.G.y Maiback H.L. Contact urticaria // Occupational Skin Disease / Ed. R.M. Adams. -N.Y.: Grune And Stratton, 1983. - P. 69.
66. Altux P. et al. Case report: the spectrum of autoimmune thyroid disease with urticaria // Am. J. Med. Sci. - 1993. - Vol. 306. - P. 379.
67. RumbyrtJ.S. et al. Resolution of chronic urticaria in patients with thyroid autoimmunity I I J. Allergy Clin. Immunol. - 1995. - Vol. 96. - P. 901.
68. Ormerod A.D. Urticaria: recognition, causes and treatment // Drugs. - 1994. - Vol. 48. - P. 5.
69. Soter N.A. Treatment of urticaria and angioedema: low-sedating H1 -type antihistamines 11 J. Am. Acad. Dermatol. - 1991. - Vol. 24. - P. 1084.
70. Grant S.M. et al. Ketotifen: a review of its pharmacodynamic and pharmacokinetics properties, and therapeutic use in asthma and allergic disorders // Drugs. - 1990. - Vol. 40. - P. 412.
272
71. Campoli-Richards D.M. et al. Cetirizine: a review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma and chronic urticaria // Ibid. - P. 762.
72. Breneman D. et al. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a doubleblind, placebo-controlled, comparative trial // J. Am. Acad. Dermatol. - 1995. - Vol. 33. - P. 192.
73. Townley R.G. Cetirizine: a new H1 antagonist with antieosinophilic activity in chronic urticaria 11 Ibid. - 1991. - Vol. 25. - P. 668.
74. Brestel E.P., Thrush L.B. The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol 11 J. Allergy Clin. Immunol. - 1988. - Vol. 82. - P. 265.
75. Bressler R.B. et al. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial // Ibid. - 1989. - Vol. 83. -P. 756.
76. Fradin M.S. et al. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema // J. Am. Acad. Dermatol. - 1991. - Vol. 25. - P. 1065.
77. Weiner M.J. Methotrexate in corticosteroid-resistant urticaria 11 Ann. Intern. Med. - 1989. -Vol. 110.-P. 848.
78. Engler R.J.M. et al. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema 11 Ann. Allergy Asthma Immunol. - 1995. - Vol. 74. - P. 1557.
